AzTrials
AzTrials

DeliriumNCT06030453

Using SMART HOME Strategy to Reduce the Incidence of Delirium in the Intensive Care Unit

A study testing SMART HOME strategy and PADIS nursing intervention in people with Delirium and Intensive Care Unit Delirium, run by National Taiwan University Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Background: Delirium not only has a high incidence rate among hospitalized patients but also increases mortality rates, causes distress to patients and their families, and adds to healthcare costs. Studies have shown that non-pharmacological preventive measures can effectively prevent delirium. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Delirium, Intensive Care Unit Delirium
What is being tested?
SMART HOME strategy and PADIS nursing intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
No sites listed yet
Study dates
1 Jan 2024to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Moderate sedation to Combative (Richmond Agitation-Sedation Scale score : -3 to +4)

Who cannot join

  • Delirium. GCS≦3. Moderate to severe dementia.

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Using SMART HOME Strategy to Reduce the Incidence of Delirium in the Intensive Care Unit: A Randomized Controlled Study

Background: Delirium not only has a high incidence rate among hospitalized patients but also increases mortality rates, causes distress to patients and their families, and adds to healthcare costs. Studies have shown that non-pharmacological preventive measures can effectively prevent delirium. However, critically ill patients with multiple tubes and devices cannot receive home care due to their unstable condition. Therefore, this study aims to design multiple measures resembling a home environment in the hospital ICU to reduce the incidence of delirium.

Objectives: Primary outcomes:the incidence and duration of delirium.Secondary outcomes :hospital stay, mortality rates, and patient or family satisfaction.

Read more

Methods and Procedures: A prospective randomized double-blind study design. The study is planned to be conduct from January 1,2024 to December 30,2024。 Prior to enrollment, informed consent forms will be obtained and patients from six ICUs in the hospital.

Inclusion criteria: Adult patients aged 18 or above. No maximum age limit. Patients with a Richmond Agitation-Sedation Scale score ranging from -3 to +4.Exclusion criteria: Patients with an existing diagnosis of delirium. Patients who were unable to communicate(GCS≦3)。 Patients with moderate to severe dementia.Patients with severe sedation or coma(GCS≦3)。 Sample Size: The control group's delirium incidence rate of 69.1% based on a study. The experimental group is expected to reduce delirium incidence rate to 40%。 A α value of 0.05, power 80%, each group will require 45 participants, total sample size 90 participants.A loss to follow-up rate about 15%。 To improve the effectiveness of the research design results, sample size is increased to 104 and each group is 52 participants.

Intervention Design:Each delirium assessment using the ICDSC, both groups will undergo routine assessment using RASS.

Control Group: Receive traditional comprehensive care in the ICU based on the PADIS assessment. This care will be administered by ICU nurses and will include pharmacological treatments as well as nursing interventions.

Experimental Group: ICDSC along with PRE-DELIRIC model. Intervention: In addition to the routine comprehensive care provided in the ICU, the experimental group will receive SMART HOME care interventions.

Outcome measures :ICDSC,PRE-DELIRIC,Incidence of Delirium,Duration of Delirium,LOS,Mortality Rate,Satisfaction.

Read the detailed description

Prevention is better than treatment, and the intensive care unit (ICU) is a critical and highly medicalized setting where patients are prone to developing delirium. Delirium is a clinical syndrome characterized by short-term or long-term complications associated with altered consciousness and cognitive impairment. Prevention is the most crucial aspect of care, rather than waiting for it to occur and providing treatment. Delirium manifests as a rapid change in the level of consciousness and cognitive impairment. Delirium not only has a high incidence rate among hospitalized patients but also increases mortality rates, causes distress to patients and their families, and adds to healthcare costs. Studies have shown that non-pharmacological preventive measures can effectively prevent delirium. Evidence suggests that providing diverse preventive measures in the home environment of delirious patients is more effective than in a rigid hospital setting. However, critically ill patients with multiple tubes and devices cannot receive home care due to their unstable condition. Therefore, this study aims to design multiple measures resembling a home environment in the hospital ICU to reduce the incidence of delirium.

This study focuses on the ICU departments , comprising a total of six units with 72 ICU beds. The Intensive Care Delirium Screening Checklist (ICDSC) and the Richmond Agitation-Sedation Scale (RASS) are used for delirium assessment and evaluation of agitation, respectively. In 2023, a delirium assessments using ICDSC was conducted in the medical ICU of a medical center in Taiwan, with occurrence rates of 69.1%. However, there is currently no empirical research on delirium prevention measures in Taiwan, and delirium is associated with increased incidence and mortality rates, prolonged hospital stays, increased hospital costs, and long-term cognitive impairment after discharge. According to the recommendations of the Society of Critical Care Medicine (SCCM), antipsychotic drugs should not be routinely used to treat delirium in critically ill adults. Non-pharmacological treatment is currently an important option for delirium management. Therefore, this project aims to develop a predictive model for ICU delirium in Taiwan, which can intervene with diverse care preventive measures before delirium occurs .

The study consists of two groups: the SMART HOME group (experimental group) and the traditional care group (control group).

A prospective randomized double-blind study design will be adopted. After obtaining approval from the hospital's Institutional Review Board (IRB), the study is planned to be conducted from January 1,2024 to December 30,2024。 Prior to enrollment, informed consent forms will be obtained from all eligible patients or their family members (for patients who are still unconscious or unable to sign the consent form)。 The study will enroll patients from the ICU departments of six units in the hospital.

The control group will have a projected delirium incidence rate of 69.1% based on a study. The experimental group is expected to reduce the delirium incidence rate to 40%。 A α value of 0.05, and a desired power of 80%, each group will require 45 participants, resulting in a total sample size of 90 participants.A loss to follow-up rate estimated at 15%。 In order to improve the effectiveness of the research design results, the total sample size is increased to 104 people .

Prior to each delirium assessment using the ICDSC, both groups will undergo routine sedation level assessment using the RASS to evaluate their level of arousal.

The control group will use the ICDSC currently used in the hospital's ICU. The ICDSC is assesses the symptoms or fluctuations in the past 8 or 24 hours: change in consciousness, inattention, disorientation, hallucination or delusion, psychomotor agitation or retardation, inappropriate speech or mood, sleep/wake cycle disturbance, and symptom fluctuations. Each symptom present is scored as one point, with a total score of ≥4 indicating the presence of delirium. The control group will receive traditional comprehensive care in the ICU based on the PADIS (pain, agitation, delirium, immobility, sleep disruption) assessment. This care will be administered by ICU nurses and will include pharmacological treatments for pain, agitation, delirium, immobility, and sleep disruption as well as nursing interventions.

The delirium assessment in the experimental group will include the ICDSC (administered by nurses) currently used in the hospital's ICU, along with the developed information system incorporates the PRE-DELIRIC model. The PRE-DELIRIC model has been externally validated in Lithuania, Argentina and Australia. The model includes ten predictive factors that are routinely recorded in medical records, such as age, APACHE II score, admission category, coma, infection, metabolic acidosis, emergency admission, blood urea nitrogen, sedative use, and 24-hour morphine dose .The PRE-DELIRIC model categorizes patients into four risk groups: low risk (0-20%)medium risk (20-40%)high risk (40-60%)and very high risk (>60%). By utilizing these risk levels, healthcare professionals can identify patients at a higher risk of developing delirium and implement appropriate preventive measures or interventions.In addition to the routine comprehensive care provided in the ICU, the experimental group will receive SMART HOME care interventions. "SMART HOME" refers to a set of interventions aimed at preventing delirium. Sleep hygiene: Providing a quiet and dim environment for at least 6 hours (earplugs, eye masks) to facilitate sleep (Score: 0-100%).Multidisciplinary collaboration: Involving a team of various specialists such as pharmacists, respiratory therapists, rehabilitation therapists, and physical therapists (Score: ≥20%).Assessment of pain/anxiety/agitation: Evaluating and assessing the levels of pain, anxiety, and agitation (Score: 0-100%).Release of tracheal tubes and restraints: Properly relieving pressure from tracheal tubes and restraints (Score: 0-100%).Time and schedule: Orienting the patient to time and providing a schedule (Score: 0-100%).Home-like environment and Hearing: Providing a comfortable environment similar to home and incorporating gentle music (Score: 0-100%).Orientation support: assisting the patient with a sense of person, time, and place (Score: 0-100%).Medication review and adjustment: Reviewing and adjusting medications as necessary (Score: ≥20%).Early mobilization and nutrition: Initiating early rehabilitation and ensuring adequate nutrition (Score: 0-100%).

The study was conducted at a medical center in northern Taiwan, specifically targeting the intensive care unit (ICU) population. The study employed a prospective, randomized, double-blind design.

Being tested
SMART HOME strategy, PADIS nursing intervention
Keywords
The incidence of delirium, The intensive care unit.
Medical subject headings
Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SMART HOME strategyCombination product

    Sleep hygiene: quiet and dim environment for 6 hours to facilitate sleep (Score: 0-100%).Multidisciplinary collaboration: pharmacists, respiratory therapists, rehabilitation therapists, and physical therapists (Score: ≥20%).Assessment : Evaluating and assessing the levels of pain, anxiety, and agitation (Score: 0-100%).Release of tracheal tubes and restraints: relieving pressure from tracheal tubes and restraints (Score: 0-100%).Time and schedule: Orienting the patient to time and a schedule (Score: 0-100%).Home-like environment and Hearing: A comfortable environment similar to home and music (Score: 0-100%).Orientation support: assisting with a sense of person, time, and place (Score: 0-100%).Medication review : Reviewing and adjusting medications (Score: ≥20%).Early mobilization and nutrition(Score: 0-100%).

  • PADIS nursing interventionCombination product

    pharmacological treatments for pain, agitation, delirium, immobility, and sleep disruption as well as nursing interventions

Study groups in NCT06030453
Study groupRoleWhat they receive
SMART HOME Care GruopExperimentalExperimental Group:"SMART HOME" refers to a set of interventions aimed at preventing delirium. Sleep hygiene.Multidisciplinary collaboration.Assessment of pain/anxiety/agitation.Release of tracheal tubes and restraints.Time and schedule.Home-like environment and Hearing.Orientation support.Medication review and adjustment.Early mobilization and nutrition.
Receives: Combination Product: SMART HOME strategy
Control GroupActive comparatorControl Group: The control group will receive traditional comprehensive care in the ICU based on the PADIS (pain, agitation, delirium, immobility, sleep disruption) assessment. This care will be administered by ICU nurses and will include pharmacological treatments for pain, agitation, delirium, immobility, and sleep disruption as well as nursing interventions.
Receives: Combination Product: PADIS nursing intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incidence of delirium.

    Incidence of Delirium: Refers to the proportion of new cases of delirium occurring in the study population after admission to the ICU (assessed using intensive care delirium screening checklist , with a score >4 point indicating delirium). It is expressed as a percentage %.

    Measured: From date of randomization until the date of first documented of delirium date or delirium ended date, assessed up to 6 months.

  2. The duration of delirium

    Duration of delirium:Refers to the time from the onset to the end of delirium in the study population after admission to the ICU. The duration can be in hours, days, or longer,Like 5 hours or 7days.

    Measured: From date of randomization until the date of first documented of delirium date or delirium ended date, assessed up to 6 months.

Secondary outcomes (3)
  1. Length of Stay

    Length of Stay: Refers to the total time the patients received treatment or observation in the hospital, measured in days.

    Measured: From date of randomization until the date of first documented of discharge or date transfer out of ICU or date of death from any cause, whichever came first, assessed up to 6 months.

  2. mortality rates

    Mortality Rate: Refers to the proportion of deaths that occurred within the study population during the hospital stay, expressed as a percentage %.

    Measured: From date of randomization until the date of first documented of discharge or date transfer out of ICU or date of death from any cause, whichever came first, assessed up to 6 months.

  3. patient or family satisfaction

    Patient or Family Satisfaction: The overall satisfaction with the new multidisciplinary care measures was assessed using a Likert five-point scale, ranging from strongly disagree to strongly agree, with scores ranging from 1 to 5 point.1 point means very dissatisfied,5 points means very satisfied.

    Measured: From date of randomization until the date of first documented of discharge or date transfer out of ICU or date of death from any cause, whichever came first, assessed up to 6 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2023
  2. Study start1 Jan 2024 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
104 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06030453
Sponsor's protocol ID
202307034RIND
Status last verified
Aug 2023
First submitted
22 Aug 2023
Last updated
11 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing SMART HOME strategy and PADIS nursing intervention in people with Delirium and Intensive Care Unit Delirium, run by National Taiwan University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pei-Yin Hsieh, MSN (886-2-23123456 ext. 263083, peiyin3111@ntuh.gov.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incidence of delirium. (time frame: From date of randomization until the date of first documented of delirium date or delirium ended date, assessed up to 6 months.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in